Northwest Biotherapeutics Sees Gains as it Receives Approval to Manufacture Immune Therapy in Germany (NWBO)

Northwest Biotherapeutics (OTC: NWBO), a biotech company based in Bethesda, Maryland, saw some slight gains again today after receiving approval for its immune therapy product. The company, which has experienced stock price increases all week, announced that its partner in Germany, Fraunhofer IZI, received approval and certification from the German equivalent of the United States’ […]